Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ed Parsley"'
Autor:
Ed Parsley, Rosemarie A Dudenhofer, Steven D. Nathan, Neil A. Ettinger, Marilyn K. Glassberg, Jeremy Feldman, Jeffrey J. Swigris, Ganesh Raghu, Parag Shah, Rahul G. Argula, Christopher S. King, Kevin R. Flaherty, Shilpa Johri, Lisa Lancaster, Peter Fernandes
Publikováno v:
Annals of the American Thoracic Society. 19(4)
Rationale: Patients with fibrotic interstitial lung disease often progress to the point of requiring supplemental oxygen. This is invariably accompanied by an impaired quality of life and limitatio...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6555731ae6e066f0147b6e7c6302bb
https://pubmed.ncbi.nlm.nih.gov/35363132
https://pubmed.ncbi.nlm.nih.gov/35363132
Autor:
Sharada A. Sarnaik, Ofelia A. Alvarez, William Owen, Murtadha Al-Khabori, Ashok Raj, Thomas Moulton, Bruce A. Barton, Charles T. Quinn, Suzie A. Noronha, Beng Fuh, Connie M. Piccone, Mark T. Gladwin, Philip Maes, Jennifer Keates-Baleeiro, Ed Parsley, Emad Salman, Nirmish Shah, Cameron K. Tebbi, Lewis L. Hsu, Abdulkareem Al-Momen, Kamar Godder, Yasser Wali, Jason M. Fixler, Claudia R. Morris, Yurdanur Kilinç, Christophe F. Chantrain, Suvankar Majumdar, Natalie L. Kamberos, Elena Cela de Julián, L. Vandy Black, Meenakshi Goyal-Khemka, Rebecca T. Gorney, Julie Kanter, Courtney D. Thornburg, Alex George, Zeynep Karakas, Betty S. Pace, Clarisse Lopes De Castro Lobo, Debra E. Cohen, Tammuella Singleton, Alexis A. Thompson, Clifford M. Takemoto, Joseph L. Lasky, Miguel R. Abboud, India Sisler, Rachelle Nuss, Shari S. Kronsberg, Claire S. Padgett, Adlette Inati, James F. Casella, Marty Emanuele, Richard A. Drachtman, Gregory J. Kato, Anne Schaefer, Anne M. Marsh
Publikováno v:
JAMA : the journal of the American Medical Association
Key PointsQuestionCan poloxamer 188, an agent that is reported to reduce blood viscosity and cell-cell interactions, effectively reduce the duration of vaso-occlusive episodes (painful crises) in hospitalized patients with sickle cell disease? Findin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e84aea32135688abaf3dfc1b204648c
https://doi.org/10.1001/jama.2021.3414
https://doi.org/10.1001/jama.2021.3414
Publikováno v:
Chest. 158:A2212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d32cac260712aeafa1f79fa2cf3ebd9
https://doi.org/10.1016/j.chest.2020.08.1891
https://doi.org/10.1016/j.chest.2020.08.1891
Publikováno v:
Pulmonary hypertension.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29bc849f5cbd9393dcd2c4997e3935d7
https://doi.org/10.1183/13993003.congress-2018.pa3037
https://doi.org/10.1183/13993003.congress-2018.pa3037
Autor:
Masataka Sugahara, Pamela White, Ed Parsley, Timothy N. Bachman, Rebecca Vanderpool, John Gorcsan, Mark T. Gladwin, Marc A. Simon, Mehdi Nouraie
Publikováno v:
JCI insight, vol 1, iss 18
BACKGROUND. Pulmonary hypertension (PH) is associated with poor outcomes, yet specific treatments only exist for a small subset of patients. The most common form of PH is that associated with left heart disease (Group 2), for which there is no approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2079ddb343fd7bb875fe3da5dbf6776b
https://escholarship.org/uc/item/2gq0r54x
https://escholarship.org/uc/item/2gq0r54x
Autor:
Virginia D. Steen, Naomi F. Rothfield, Ed Parsley, Carla Maynetto, Sarinnapha Vasunilashorn, Jeffrey Golden, Edrick Forbes, Xiaohong Yan, Mildred Sterz, Jonathan G. Goldin, Donald P. Tashkin, David J. Riley, Marcie Bolster, Arthur C. Theodore, Deborah A. McCloskey, Irene Da Costa, Anise Carey, Fran Ingenito, Macha Aberles, Barbara White, Michael F. Bonner, Joanie Chung, Robert D. Suh, Sean Wheaton, Ken Bulpitt, James R. Seibold, Daniel Furst, José L. Granda, Marcy B. Bolster, Philip J. Clements, Adriana Ortiz, Mark Bohlman, June Arnold, Kimberley Tobin, Elena Breen, Robert E. Elashoff, Colleen Sanders, Sherrie Viasco, David Lapota, Ronika Alexander, Judy Ho, Maureen Mayes, Kamal K. Mubarak, Steve Schabel, Richard M. Silver, Robert W. Simms, Michael Roth, Charlie Strange, Amanda Mondt, J H Korn, Wen Ling Joanie Chung, Vivien Hsu, Laura K. Hummers, Richard I. Silver, Mark Metersky, Fred M. Wigley, Katie Caldwell, Albert J. Polito, Tan Filemon, Sandra A. A. Oldham, Robert Elashoff, John Varga, John A. Davis, Shiva Arami, Edwin Smith, Andrew Wilbur, Dinesh Khanna, Mitchell A. Olman, Melynn Nuite, Tina Parkhill, Patricia Cole-Saffold, Peter Clarke, Robert A. Wise, Gwen Leatherman, Christine Antolos, Joseph Silva, Barri J. Fessler, Edwin A. Smith, Louis W. Heck, Marilyn Perry, Paul Wolters, Julianne E. Wilson, Lovlette Woolcock, Jerry A. Molitor, Daniel E. Furst, Richard Cobb, Steven Kirkland, Dean Schraufnagel, Judith K. Amorosa, Zora Injic, Samantha Jordan, Richard Hinke, Michael D. Roth, Charles A. Read, Richard Webb, Kari Connolly, Marie Daniel, Cirrelda Cooper, Steven Springmeyer
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 177:91-98
The presence of inflammatory cells on bronchoalveolar lavage is often used to predict disease activity and the need for therapy in systemic sclerosis-associated interstitial lung disease.To evaluate whether lavage cellularity identifies distinct subs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55b7880bc02886dade9670a775f1f695
https://doi.org/10.1164/rccm.200705-655oc
https://doi.org/10.1164/rccm.200705-655oc
Autor:
Robert W. Simms, Philip J. Clements, Virginia D. Steen, Charlie Strange, Robert A. Wise, Mark L. Metersky, Vivien Hsu, Fredrick M. Wigley, Naomi F. Rothfield, Marcy B. Bolster, B. J. Fessler, Dean E. Schraufnagel, Daniel E. Furst, Arthur C. Theodore, David J. Riley, Dinesh Khanna, Michael D. Roth, Charles A. Read, Kamal K. Mubarak, Richard M. Silver, Ed Parsley, James R. Seibold, M. Kari Connolly, Barbara White, Xiaohong Yan, Mitchell A. Olman, Robert Elashoff, Maureen D. Mayes, Donald P. Tashkin, Jeffrey A. Golden, John Varga
Publikováno v:
Arthritis & Rheumatism. 56:1676-1684
Objective To assess the impact of cyclophosphamide (CYC) on the health-related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. Methods One hundred fifty-eight subjects participated in the Scleroderma Lung Study, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989aa00dbc2e72f1c649ed231a98c06f
https://doi.org/10.1002/art.22580
https://doi.org/10.1002/art.22580
Autor:
Edgar Arriola, Arthur C. Theodore, Robert W. Simms, Charlie Strange, Philip J. Clements, Virginia D. Steen, Naomi F. Rothfield, Kamal K. Mubarak, B. J. Fessler, M. Kari Connolly, Vivien Hsu, Mark L. Metersky, Fredrick M. Wigley, Jonathan G. Goldin, Daniel E. Furst, Ed Parsley, James R. Seibold, Barbara White, John Varga, Robert A. Wise, Richard M. Silver, Michael D. Roth, Charles A. Read, Jeffrey A. Golden, Dean E. Schraufnagel, Robert Elashoff, Maureen D. Mayes, Donald P. Tashkin, Mitchell A. Olman, Marcy B. Bolster, David J. Riley
Publikováno v:
New England Journal of Medicine. 354:2655-2666
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on lung function and health-related symptoms in patients with evidence of active alveolitis and scleroderma-related interst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982e211a2b9e8c3832e95be06ef601c2
https://doi.org/10.1056/nejmoa055120
https://doi.org/10.1056/nejmoa055120
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 286:L1202-L1209
The mechanism of chronic lung inflammation leading to lung fibrosis is unknown and does not have a characteristic inflammatory macrophage phenotype. This study was undertaken to determine whether a change in macrophage phenotype could account for chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38b036a04ceebf591bb03b4607a013d
https://doi.org/10.1152/ajplung.00351.2003
https://doi.org/10.1152/ajplung.00351.2003
Publikováno v:
C63. MANAGEMENT OF PULMONARY HYPERTENSION.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d986184c2b77172cdf25c29d055d4b9a
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4800
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4800